CHRISTINA WOLF: Open Payments
NPI 1255619961 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 144 payments from 22 companies in 2025. Trend: 2023 $2,425 · 2024 $3,044 · 2025 $2,701
Food & beverage: $2,701
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 72 | $971 |
| AstraZeneca Pharmaceuticals LP | 5 | $362 |
| GENZYME CORPORATION | 10 | $297 |
| Grifols USA, LLC | 11 | $169 |
| Actelion Pharmaceuticals US, Inc. | 7 | $137 |
| Verona Pharma, Inc. | 8 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Insmed, Inc. | 4 | $78 |
| Merck Sharp & Dohme LLC | 3 | $65 |
Products named: NUCALA, DUPIXENT, FASENRA, TRELEGY ELLIPTA, Prolastin-C Liquid, UPTRAVI, Ohtuvayre, GLASSIA.
Industry payments across KY — which companies pay providers there.
